Mavens Biotech is currently trading at Rs. 2.28, up by 0.23 points or 11.22% from its previous closing of Rs. 2.05 on the BSE.
The scrip opened at Rs. 2.10 and has touched a high and low of Rs. 2.34 and Rs. 2.08 respectively. So far 452040 shares were traded on the counter.
The BSE group 'B' stock of face value Rs. 1 has touched a 52 week high of Rs. 3.73 on 30-Sep-2011 and a 52 week low of Rs. 1.51 on 22-Aug-2012.
Last one week high and low of the scrip stood at Rs. 2.34 and Rs. 1.65 respectively. The current market cap of the company is Rs. 25.06 crore.
The promoters holding in the company stood at 32.04% while Non-Institutions held 67.96% stake in the company.
Mavens Biotech has entered into seed production business from last rabi season. This is a pilot project in the seeds sector and will enable the company to set up a quality seed production center with best practice and cater to the growing needs of the farmers for quality planting material. The company has initially taken six acres agricultural land on lease in Manchar district, near Pune in Maharashtra for the said purpose and produced 1.5 ton best quality onion seeds in the last rabi season.
Besides, the company is in process to take more land on lease to expand its seeds production. It proposes to produce ten tons Maize seeds in this season and the company is selling these seeds directly to the farmers of Maharashtra region.
Further, the company is planning to setup a secondary nutrients fertilizer granulation plant at Manchar, Pune with a capacity of 100 ton per month. The company is targeting Maharashtra state in first phase and thereafter throughout India for sale of secondary nutrients. The company has also decided to set up a processing unit for Neem Powder/ Pellets and its related products for agriculture use at Manchar, Pune.
| Company Name | CMP |
|---|---|
| Redington | 276.10 |
| Amrapali Industries | 32.28 |
| Adani Enterprises | 3036.10 |
| Rashi Peripheral | 772.40 |
| PDS | 364.15 |
| View more.. | |
Start Research-backed Investing ...Now. Subscribe to Sapphire
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: